Calcitonin has been approved for the treatment of postmenopausal
osteoporosis, hypercalcemia of malignancy, and Paget's disease of the bone.Several sources are available
(e.g., eel, human, salmon, and porcine). The calcitonin isolated from salmon is the preferred source, because it
has greater receptor affinity and a longer half-life than the human hormone.
